Evidence map›Paper›PMID 23899014›Full record

ArticleJournal of computational biology : a journal of computational molecular cell biology2013

Symbolic data analysis to defy low signal-to-noise ratio in microarray data for breast cancer prognosis.

Lyamine Hedjazi, Marie-Veronique Le Lann, Tatiana Kempowsky, Florence Dalenc, Joseph Aguilar-Martin, Gilles Favre

Abstract read
In one paragraph

Article in Journal of computational biology : a journal of computational molecular cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lyamine HedjaziCNRS, LAAS, Toulouse, France. lhedjazi@laas.fr
Marie-Veronique Le Lann
Tatiana Kempowsky
Florence Dalenc
Joseph Aguilar-Martin
Gilles Favre

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microarray profiling has recently generated the hope to gain new insights into breast cancer biology and thereby improve the performance of current prognostic tools. However, it also poses several serious challenges to classical data analysis techniques related to the characteristics of resulting data, mainly high dimensionality and low signal-to-noise ratio. Despite the tremendous research work performed to handle the first challenge in the feature selection framework, very little attention has been directed to address the second one. We propose in this article to address both issues simultaneously based on symbolic data analysis capabilities in order to derive more accurate genetic marker-based prognostic models. In particular, interval data representation is employed to model various uncertainties in microarray measurements. A recent feature selection algorithm that handles symbolic interval data is used then to derive a genetic signature. The predictive value of the derived signature is then assessed by following a rigorous experimental setup and compared with existing prognostic approaches in terms of predictive performance and estimated survival probability. It is shown that the derived signature (GenSym) performs significantly better than other prognostic models, including the 70-gene signature, St. Gallen, and National Institutes of Health criteria.

Indexed as

AlgorithmsGene Expression ProfilingOligonucleotide Array Sequence AnalysisSignal-To-Noise RatioBiomarkers, TumorBreast NeoplasmsComputational BiologyDatabases, GeneticData MiningFemaleHumansMiddle AgedModels, StatisticalPattern Recognition, AutomatedPrognosisSurvival RateBiomarkers, Tumor

Identifiers

PMID23899014
PMCPMC3728725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.